Bristol-Myers Squibb
BMY
BMY
2,444 hedge funds and large institutions have $97.1B invested in Bristol-Myers Squibb in 2025 Q1 according to their latest regulatory filings, with 199 funds opening new positions, 937 increasing their positions, 975 reducing their positions, and 165 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,444
Holders Change
-14
Holders Change %
-0.57%
% of All Funds
33.2%
Holding in Top 10
35
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-10.26%
% of All Funds
0.48%
New
199
Increased
937
Reduced
975
Closed
165
Calls
$1.73B
Puts
$1.7B
Net Calls
+$26M
Net Calls Change
+$18.1M
Top Buyers
| 1 |
Capital International Investors
Los Angeles,
California
|
+$1.26B |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.08B |
| 3 |
JPMorgan Chase & Co
New York
|
+$734M |
| 4 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$730M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$281M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$579M |
| 2 |
Millennium Management
New York
|
-$484M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$355M |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
-$300M |
| 5 |
VanEck Associates
New York
|
-$249M |